A unique hinge binder of extremely selective aminopyridine-based Mps1 (TTK) kinase inhibitors with cellular activity

Ken‐ichi Kusakabe(Futaba (Japan)), Yusuke Nakamura(Yokohama University of Pharmacy), Masayo Higaki(Shiga University of Medical Science), Motofumi Iguchi(Futaba (Japan)), Genta Tadano(Futaba (Japan)), Nobuyuki Ide(Futaba (Japan)), Shingo Sakamoto(Shiga University of Medical Science), Shigeru Ando(Futaba (Japan)), Yasuto Kido(Shiga University of Medical Science), Yasunori Mitsuoka(Shionogi (Japan)), Sachie Tagashira(Futaba (Japan)), Hidenori Yoshizawa(Futaba (Japan)), Yuji Sato(Futaba (Japan)), Takeshi Itoh(Futaba (Japan)), Keiji Dohi(Futaba (Japan)), Eiichi Kojima(Shionogi (Japan)), Takayuki Kanazawa(Futaba (Japan)), Takahiko Yamamoto(Shiga University of Medical Science), Kenichi Higashino(Shiga University of Medical Science), Y. Okano(Shiga University of Medical Science), Yukichi Ishioka(Futaba (Japan)), Makiko Inoue(Howard Hughes Medical Institute), Masahiro Maeda(Shiga University of Medical Science), Hitoshi Murai(Futaba (Japan)), Yataro Daigo(The University of Tokyo)
Bioorganic & Medicinal Chemistry
March 4, 2015
Cited by 20


Related Papers